Re-establishment of neuromuscular block by rocuronium after sugammadex administration

  • Joaquin Fabregat-López
  • Gloria Veiga-Ruiz
  • Nuria Dominguez-Serrano
  • Maria Rosario García-Martinez

To the Editor,

Patients occasionally may require reoperation in the immediate postoperative period. We present a case where rocuronium-induced neuromuscular block (NMB) was achieved more than 2 h after sugammadex had been given. Written consent for publication of the manuscript was granted by the patient.

A 65-year-old man (American Society of Anesthesiologists physical status III, weight 95 kg, body mass index 29.3 kg m−2) with a history of hypertension, dyslipidemia, and symptoms suggesting carotid vascular disease was scheduled for left carotid endarterectomy. Laboratory values were within normal limits. Two hours after the procedure while the patient was in the postanesthesia care unit, he developed an expanding neck hematoma without airway compromise and was brought back to the operating room for hematoma evacuation.

Following preoxygenation, anesthesia was induced slowly with fentanyl 100 μg, etomidate 15 mg, and rocuronium 50 mg (0.53 mg kg−1). Once the patient was unconscious,...


Remifentanil Rocuronium Etomidate Neuromuscular Block Adductor Pollicis 



The authors sincerely thank Professor Aaron F. Kopman, Weill Cornell Medical College, for his helpful assistance with manuscript revision and Dr. Lucas Mengibar Fuentes, vascular surgeon, for his collaboration in patient care.

Conflicts of interest

Gloria Veiga-Ruiz, Nuria Dominguez-Serrano, and Joaquin Fabregat-López have received speakers’ fees from MSD. No external funding and no competing interest declared.


  1. 1.
    Staals LM, Snoeck MM, Driessen JJ, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104: 31-9.CrossRefGoogle Scholar
  2. 2.
    de Boer HD, Driessen JJ, van Egmond J, Booij LH. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anesth 2008; 55: 124-5.CrossRefGoogle Scholar
  3. 3.
    Cammu G, de Kam PJ, De Graeve K, et al. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study. Br J Anaesth 2010; 105: 487-92.CrossRefGoogle Scholar
  4. 4.
    Kopman AF. Managing neuromuscular block: where are the guidelines? Anesth Analg 2010; 111: 9-10.CrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists' Society 2011

Authors and Affiliations

  • Joaquin Fabregat-López
    • 1
  • Gloria Veiga-Ruiz
    • 1
  • Nuria Dominguez-Serrano
    • 1
  • Maria Rosario García-Martinez
    • 1
  1. 1.University Hospital Rosell CartagenaMurciaSpain

Personalised recommendations